#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Obliterative bronchiolitis Muscular dystrophy Arginase deficiency Angiosarcoma Diabetes insipidus Congenital cystic kidney disease Atopic keratoconjunctivitis Burkitt's lymphoma Pemphigus Immunoglobulin G4 related disease Mantle cell lymphoma Alternating hemiplegia of childhood Ovarian epithelial cancer Glioblastoma More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Treatment Ocular melanoma – Basic Information Hyperoxaluria – Basic Information Undifferentiated sarcoma – Basic Information Cholangitis sclerosing – Basic Information Alport’s syndrome – Treatment Ewing’s sarcoma metastatic – Treatment Alport’s syndrome – Diagnostics Crigler-Najjar syndrome Progressive multifocal leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levoleucovorin Disodium Irinotecan CARBOMER 980 Damoctocog Alfa Pegol Tanimilast Tegoprubart Pentixather Glucagon Darolutamide Poa Pratensis Pollen Extract Kk8123 Lavender Oil Alendronate Sodium Monohydrate Elezanumab Remestemcel IM-101 Imgn151 Bemarituzumab Levomepromazine Hydrochloride ALN-961583 More therapies…

    Learn about Your Condition

    Propionic acidaemia Inborn error of metabolism Herpes simplex Insulin resistance Adrenogenital syndrome Breast cancer stage I Biliary cancer metastatic Hodgkin's disease recurrent Intervertebral disc protrusion Lymphoma Tachypnoea Radiation skin injury Brain abscess Adrenocortical carcinoma Thalassaemia alpha More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukemia Using Etoposide, Treosulfan, and Thiotepa

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Anti-Human T-Lymphocyte Immunoglobulin From Rabbits
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Blinatumomab
    Austria Belgium Czechia Denmark France Germany +6

  • Study on Luspatercept and Epoetin Alfa for Patients with Low-Risk Myelodysplastic Syndrome Without Ring Sideroblasts Who Did Not Respond to ESA

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Luspatercept
    • Epoetin Alfa
    France Italy

  • Study on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Primary myelofibrosis
    Investigated Drugs:
    • Tasquinimod
    Germany The Netherlands

  • Study Comparing Venetoclax and Azacitidine with Standard Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients with NPM1 Mutations Eligible for Intensive Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Mitoxantrone
    • Azacitidine
    Germany

  • Study on the Safety and Effectiveness of AZD5492 Alone or with Other Treatments for Adults with Relapsed or Refractory B-Cell Blood Cancers

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Azd5492
    Denmark France Germany Italy Spain

  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Isatuximab
    • Ponatinib
    • Blinatumomab
    Belgium France
Previous Page
1 … 32 33 34 35 36 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!